在生物医学先进研究和开发权威机构内建立对新出现的传染病的快速反应能力
Robert A Johnson1, Terence M Barnhart1, Gary L Disbrow1
1Robert A. Johnson, PhD, is Director, Medical Countermeasures Programs, and Gary L. Disbrow, PhD, is Director, Center for Biomedical Advanced Research and Development Authority (BARDA), Washington, DC. Terence M. Barnhart, PhD, is Senior Strategy Implementation Leader, Tunnell Government Services, Inc. (Contractor Supporting BARDA), Washington, DC.
Health security
|January 15, 2025
概括
生物医学先进研究和开发中心 (BARDA) 概述了一种战略方法,通过优先考虑平台技术和增强国家安全响应能力来打击新出现的传染病.
科学领域:
- 生物医学研究的研究.
- 公共卫生安全 公共卫生安全
- 传染病防治准备工作
背景情况:
- 新出现的传染病对国家安全和公共卫生构成重大威胁.
- 生物医学先进研究和开发中心 (BARDA) 支持针对公共卫生威胁的医学对策 (MCM).
- 为所有潜在的新出现的疾病开发MCM是不可能的.
研究的目的:
- 描述BARDA应对新出现的传染病的战略方法.
- 概述制定和改进医疗对策的计划.
- 加强国家对公共卫生安全威胁的准备.
主要方法:
- 优先考虑使用平台技术对特定病原体的MCM开发.
- 通过授权的MCM和快速开发基础设施建立响应能力.
- 持续改进响应能力,以实现最佳准备.
主要成果:
- 为应对新出现的传染病制定了三步策略.
- 专注于平台技术使MCM能够快速发展.
- 开发MCM和灵活的基础设施对于应对至关重要.
结论:
- 巴达的战略旨在建立一个强大的系统来打击新出现的传染病.
- 优先级和平台技术是高效MCM开发的关键.
- 对应能力的持续改进确保了对未来威胁的准备.
相关概念视频
01:18Steps in Outbreak Investigation
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...